Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Daiichi Sankyo
Teva
Cipla
Citi
Julphar
Federal Trade Commission
Fuji

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203554

« Back to Dashboard

NDA 203554 describes PENTOSTATIN, which is a drug marketed by Mylan Institutional and West-ward Pharms Int and is included in two NDAs. Additional details are available on the PENTOSTATIN profile page.

The generic ingredient in PENTOSTATIN is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
Summary for 203554
Tradename:PENTOSTATIN
Applicant:Mylan Institutional
Ingredient:pentostatin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 203554

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Sep 19, 2014TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
Healthtrust
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Chinese Patent Office
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.